A. Ahmann

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
A J Ahmann, Andrew Ahmann, Andrew J Ahmann, A. Ahmann, A. J. Ahmann, A Ahmann, Andrew J. Ahmann
Publication record
100 papers · 9,508 citations · H-index 36

PAPERS

Weight Gain Was Associated With Worsening Glycemia and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes Independent of Diabetes Medication in the GRADE Randomized Controlled Trial.
20252 citationsauthor #6
A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes.
202531 citationsauthor #8
Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial.
20248 citationsauthor #8
Relationship Between Average Glucose Levels and HbA1c Differs Across Racial Groups: A Substudy of the GRADE Randomized Trial.
20246 citationsauthor #6
Impact of Prescribing Patterns Before and After Short-Term, Pharmacist-Led Type 2 Diabetes Service in an Endocrinology Clinic.
20240 citationsauthor #6
Proportion of participants with type 2 diabetes achieving a metabolic composite endpoint with once‐weekly semaglutide treatment versus comparators: Post hoc pooled analysis from SUSTAIN 1‐5, 7‐10 and SUSTAIN China
20234 citationsauthor #3
213-OR: ADA Presidents' Select Abstract: EMBARK—A Randomized, Controlled Trial Comparing Three Approaches to Reducing Diabetes Distress in Adults with Type 1 Diabetes
20231 citationsauthor #10
746-P: Semaglutide Increases the Proportion of People with T2D Achieving a Metabolic Composite Endpoint
20231 citationsauthor #2
1023-P: Current Practices in Racial Equity—Findings from the T1D Exchange Quality Improvement Collaborative (T1DX-QI) in 2022
20230 citationsauthor #7
The Use of Rescue Insulin in the Glycemia Reduction Approaches in Type 2 Diabetes: A Comparative Effectiveness Study (GRADE).
20234 citationsauthor #5
Higher burden of cardiometabolic and socioeconomic risk factors in women with type 2 diabetes: an analysis of the Glycemic Reduction Approaches in Diabetes (GRADE) baseline cohort
20230 citationsauthor #10
Clinical and Metabolic Characterization of Adults With Type 2 Diabetes by Age in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) Cohort
20221 citationsauthor #207
Clinical and Metabolic Characterization of Adults With Type 2 Diabetes by Age in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) Cohort.
20220 citationsauthor #7
Implementation of a pharmacist-led diabetes management service in an endocrinology clinic.
20225 citationsauthor #3
Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 Diabetes
202254 citationsauthor #4
Clinical and Metabolic Characterization of Adults With Type 2 Diabetes by Age in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) Cohort
20221 citationsauthor #7
Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring
202178 citationsauthor #2
The cross-sectional association of cognition with diabetic peripheral and autonomic neuropathy-The GRADE study.
20218 citationsauthor #4
Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
2020290 citationsauthor #4
Review for "Efficacy and safety of once‐weekly semaglutide vs once‐daily sitagliptin as add‐on to metformin in patients with type 2 diabetes ( SUSTAIN China): a 30‐week double‐blind, phase 3a, randomised trial"
20201 citationsauthor #1
How COVID-19 Rapidly Transformed Clinical Practice at the Harold Schnitzer Diabetes Health Center Now and for the Future
20209 citationsauthor #3
823-P: Characteristics of Type 1 Diabetes (T1D) Patients Attending a Young Adult Diabetes Clinic (YADC) as a Component of Transition from Pediatric to Adult Diabetes Care
20192 citationsauthor #6
1141-P: Detailed Phenotype of Randomized Participants by Age in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)
20190 citationsauthor #6
Hypoglycemia and Glycemic Control in Older Adults With Type 1 Diabetes: Baseline Results From the WISDM Study
201937 citationsauthor #4
OR22-2 Exposure to Hypoglycemia in Older Adults with Type 1 Diabetes: Baseline Characteristics Using Continuous Glucose Monitoring Data
20197 citationsauthor #4
Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1-7 trials.
2019223 citationsauthor #2
Rudimentary Physics with Python: An Application of Python Computer Algebra to Perform Calculus-based Kinematic Analysis
20190 citationsauthor #1
Advances in Glucose Monitoring and Automated Insulin Delivery: Supplement to Endocrine Society Clinical Practice Guidelines
201819 citationsauthor #2
T1-REDEEM: A Randomized Controlled Trial to Reduce Diabetes Distress Among Adults With Type 1 Diabetes
201888 citationsauthor #8
Semaglutide provides superior glycemic control across SUSTAIN 1–5 clinical trials
20188 citationsauthor #1
Approach to Using Trend Arrows in the FreeStyle Libre Flash Glucose Monitoring Systems in Adults
201887 citationsauthor #2
Continuous Glucose Monitoring with Multiple Daily Insulin Treatment: Outcome Studies
201735 citationsauthor #2
Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial
20171,036 citationsauthor #4
Comparison of Insulin Glargine 300 Units/mL and 100 Units/mL in Adults With Type 1 Diabetes: Continuous Glucose Monitoring Profiles and Variability Using Morning or Evening Injections
201735 citationsauthor #7
A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System for the Management of Adults With Diabetes
201792 citationsauthor #3
REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Well-Controlled Adults With Type 1 Diabetes
201710 citationsauthor #9
Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial.
2017488 citationsauthor #4
Comparison of Insulin Glargine 300 U / mL and 100 U / mL in Adults With Type 1 Diabetes : Continuous Glucose Monitoring Profiles and Variability Using Morning or Evening Injections
201785 citationsauthor #7
Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial
2017463 citationsauthor #1
Hypoglycemia prevention and user acceptance of an insulin pump system with predictive low glucose management
20170 citationsauthor #4
Reliability of Trained Dogs to Alert to Hypoglycemia in Patients With Type 1 Diabetes
201736 citationsauthor #4
REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes
2017273 citationsauthor #9
Effect of Continuous Glucose Monitoring on Glycemic Control in Adults Using Multiple Daily Insulin Injections
20170 citationsauthor #6
Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.
2017104 citationsauthor #5
Glucose Variability in a 26-Week Randomized Comparison of Mealtime Treatment With Rapid-Acting Insulin Versus GLP-1 Agonist in Participants With Type 2 Diabetes at High Cardiovascular Risk
2016122 citationsauthor #4
Diabetes Technology-Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline.
2016200 citationsauthor #2
Efficacy and Safety of Once-Weekly Semaglutide vs. Exenatide ER after 56 Weeks in Subjects with Type 2 Diabetes (SUSTAIN 3)
201619 citationsauthor #2
Response to Comment on Rickels et al. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. Diabetes Care 2016;39:264–270
201613 citationsauthor #11
Risk Factors Associated With Severe Hypoglycemia in Older Adults With Type 1 Diabetes
2015148 citationsauthor #21
Efficacy and safety of liraglutide versus placebo added to basal insulin analogues (with or without metformin) in patients with type 2 diabetes: a randomized, placebo‐controlled trial
201595 citationsauthor #1
Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study
2015105 citationsauthor #11
Hypoglycemia Reduction and Changes in Hemoglobin A1c in the ASPIRE In-Home Study
201552 citationsauthor #5
Prevalence of Detectable C-Peptide According to Age at Diagnosis and Duration of Type 1 Diabetes
2014220 citationsauthor #10
Efficacy and Safety of Liraglutide vs. Placebo When Added to Basal Insulin Analogues in Subjects with Type 2 Diabetes (LIRA-ADD2BASAL): A Randomized, Placebo-Controlled Trial
20142 citationsauthor #2
PO410 EFFICACY AND SAFETY OF LIRAGLUTIDE VS PLACEBO WHEN ADDED TO BASAL INSULIN ANALOGUES IN SUBJECTS WITH TYPE 2 DIABETES (LIRA-ADD2BASAL): A RANDOMISED, PLACEBO-CONTROLLED TRIAL
20144 citationsauthor #1
Real-Time Continuous Glucose Monitoring Among Participants in the T1D Exchange Clinic Registry
2014297 citationsauthor #6
Comparing Patient Preferences and Healthcare Provider Recommendations with the Pen Versus Vial-and-Syringe Insulin Delivery in Patients with Type 2 Diabetes
201438 citationsauthor #1
Accuracy and Acceptability of the 6-Day Enlite Continuous Subcutaneous Glucose Sensor
201494 citationsauthor #2
Recommendations for Standardizing Glucose Reporting and Analysis to Optimize Clinical Decision Making in Diabetes: The Ambulatory Glucose Profile (AGP)
2013285 citationsauthor #2
Threshold-based insulin-pump interruption for reduction of hypoglycemia.
2013622 citationsauthor #7
Recommendations for Standardizing Glucose Reporting and Analysis to Optimize Clinical Decision Making in Diabetes: The Ambulatory Glucose Profile
2013162 citationsauthor #2
ASPIRE in-Home: Rationale, Design, and Methods of a Study to Evaluate the Safety and Efficacy of Automatic Insulin Suspension for Nocturnal Hypoglycemia
201311 citationsauthor #7
Can Trained Dogs Detect a Hypoglycemic Scent in Patients With Type 1 Diabetes?
201330 citationsauthor #7
Inpatient Management of Diabetes
20120 citationsauthor #2
Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function
2012315 citationsauthor #7
CMF6 – Inpatient Management of Diabetes
20120 citationsauthor #2
Application of comparative effectiveness research in evaluation of treatments for type 2 diabetes mellitus.
20113 citationsauthor #1
Sensor-Augmented Pump Therapy for A1C Reduction (STAR 3) Study
2011118 citationsauthor #3
NEW THERAPIES IN TYPE 1 DIABETES Inflammatory markers are increased in youth with type 1 diabetes : the SEARCH case – control study
20110 citationsauthor #8
Treating to target: implementing an effective diabetes care paradigm for managed care.
20109 citationsauthor #2
Patient-specific insulin-resistance-guided infusion improves glycemic control in cardiac surgery.
20106 citationsauthor #7
Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes.
2010838 citationsauthor #3
Insulin Therapy Guided by Patient-Specific Insulin Resistance Improves Glycemic Control in Cardiovascular Surgery Patients
20100 citationsauthor #8
Designing and implementing insulin infusion protocols and order sets.
200820 citationsauthor #1
The Impact of Diabetes and Associated Cardiometabolic Risk Factors on Members: Strategies for Optimizing Outcomes
200844 citationsauthor #2
Safety profile and metabolic effects of 14 days of treatment with DIO-902: results of a phase IIa multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in patients with type 2 diabetes mellitus.
200830 citationsauthor #3
Advancing Insulin Therapy in Type 2 Diabetes Previously Treated With Glargine Plus Oral Agents
2007203 citationsauthor #2
Guidelines and performance measures for diabetes.
200771 citationsauthor #1
Reply to WJ McCarthy
20050 citationsauthor #2
Management of diabetes and hyperglycemia in hospitals.
20041,283 citationsauthor #4
What to do when two oral agents fail to control type 2 diabetes--a matter of opinion or a matter of fact?
20045 citationsauthor #1
Reduction of hospital costs and length of stay by good control of blood glucose levels.
200445 citationsauthor #1
Analysis: Lessons on Developing a Better Basal Insulin
20042 citationsauthor #1
Effects of a low-fat diet compared with those of a high-monounsaturated fat diet on body weight, plasma lipids and lipoproteins, and glycemic control in type 2 diabetes.
2004154 citationsauthor #2
Inpatient management of hospitalized patients with type 2 diabetes
20047 citationsauthor #1
Erratum: Management of diabetes and hyperglycemia in hospitals (Technical Review) (Diabetes Care (2004) 27 (553-591))
200425 citationsauthor #4
Managing noncardiovascular complications of diabetes
20031 citationsauthor #1
Insulin therapy in type 2 diabetes mellitus
20029 citationsauthor #1
Current oral agents for type 2 diabetes
200219 citationsauthor #1
Comprehensive management of the hospitalized patient with diabetes
199818 citationsauthor #1
ENDOCRINE-METABOLIC EFFECTS OF ASTHMA TREATMENT: The Impact of Glucocorticoid Therapy in the Elderly
19972 citationsauthor #1
[Molecular genetic detection of polyclonal immune response in autoimmune thyroiditis and inflammatory bowel diseases].
19892 citationsauthor #5
Effects of epidermal growth factor on thyroglobulin and adenosine 3',5'-monophosphate production by cultured human thyrocytes.
198915 citationsauthor #4
Thyrotropin modulates receptors for atrial natriuretic peptide on intact human thyroid cells.
198911 citationsauthor #3
Immunoglobulin and T cell antigen receptor gene arrangements indicate that the immune response in autoimmune thyroid disease is polyclonal.
198816 citationsauthor #7
Antibodies to porcine eye muscle in patients with Graves' ophthalmopathy: identification of serum immunoglobulins directed against unique determinants by immunoblotting and enzyme-linked immunosorbent assay.
198766 citationsauthor #1
Organization Section
19870 citationsauthor #5
The role of T lymphocytes in autoimmune thyroid disease.
198729 citationsauthor #1
A Continuous Publication, Open Access, Peer-reviewed Journal Evaluation of Combination Therapy in Type 2 Diabetes Mellitus: Adding Empagliflozin to Basal Insulin Combination Therapy with Insulin Key Secondary Outcome Measures
year unknown5 citationsauthor #5
Diagnostic and Therapeutic Considerations in Adults with Diabetes Mellitus Case Studies
year unknown0 citationsauthor #2

TIMELINE

1987 95 citations

1988 16 citations

1989 28 citations

1997 2 citations

1998 18 citations

2002 28 citations

2003 1 citations

2004 1,521 citations

2005 0 citations

2007 274 citations

2008 94 citations

2010 853 citations

2011 121 citations

2012 315 citations

2013 1,110 citations

2014 655 citations

2015 400 citations

2016 354 citations

2017 2,657 citations

2018 202 citations

2019 269 citations

2020 300 citations

2021 86 citations

2022 60 citations

2023 10 citations

2024 14 citations

2025 33 citations

Unknown 5 citations

A. Ahmann

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT